Multiple Sclerosis - Double-Blind Placebo Control Safety and Feasibility Study

Charité University, Berlin, Germany; University Medical Center Hamburg-Eppendorf, Hamburg, Germany

21 March, 2010

Charité University, Berlin, Germany:

Contact: Dr. Friedemann Paul; +49 (30) 450 639705, friedemann.paul@charite.de
Principal Investigator: Dr. Friedemann Paul

University Medical Center Hamburg-Eppendorf, Hamburg, Germany:

Contact: Dr. Sven Schippling; + (49) 40 42803279, s.schippling@uke.uni-hamburg.de
Principal Investigator: Dr. Sven Schippling